Description
CEFIDIS DISPERSIBLE TABLETS
CEFIDIS, brand of cefixime, is a third generation oral cephalosporin. It is advocated for susceptible infections of the respiratory and urinary tracts, uncomplicated gonorrhea, typhoid and paratyphoid (enteric fever) – especially multidrug resistant (MDR).
Cefixime (CEFIDIS) exerts its antibacterial activity by binding to and inhibiting the action of cell wall synthetic enzymes, penicillin binding proteins which results in interruption of bacterial cell biosynthesis leading to bacterial cell lysis and death.
Composition
Each uncoated dispersible tablet of CEFIDIS 50 contains:
Cefixime (As Trihydrate) USP
eq. to Anhydrous Cefixime … 50 mg
Excipients …………………..… q.s.
Each uncoated dispersible tablet of CEFIDIS 100 contains:
Cefixime (As Trihydrate) USP
eq. to Anhydrous Cefixime … 100 mg
Excipients …………………….… q.s.
Each uncoated dispersible tablet of CEFIDIS 200 contains:
Cefixime (As Trihydrate) USP
eq. to Anhydrous Cefixime … 200 mg
Excipients ……………………….. q.s.
Indications:
CEFIDIS is indicated for the treatment of following infections caused by susceptible bacteria:
- Upper respiratory tract infections, such as pharyngitis, sinusitis, otitis media, tonsillitis.
- Lower respiratory tract infections, such as acute bronchitis and acute exacerbation of chronic bronchitis.
- Uncomplicated urinary tract infections.
- Uncomplicated gonorrhea.
- MDR typhoid and paratyphoid (enteric fever).
PRESENTATION:
Strip of 10 tablets
STORAGE
Store below 30ºC. Protect from light.
Keep out of reach of children.
SHELF LIFE
2 years from the date of manufacturing.
